Executive Director of the agency, Dr Faisal Shuaib made the
announcement on Tuesday during a media briefing at Abuja.
He also said that the administration of AstraZeneca has
continued in the country after the receipt of 1,394,480 doses from the COVAX
facility.
The NPHCDA boss revealed that the National Agency for Food
and Drug Administration and Control has started working to ensure proper
serialisation of the Johnson and Johnson vaccine before it is administered to
members of the public.
He noted that Nigeria received 1,123,200 doses of the J and
J vaccine on Saturday, September 4.
“We received 1,123,200 doses of the Johnson and Johnson
COVID-19 vaccine late evening on Saturday, September 4, 2021, through the AVATT
platform, coordinated by the African Union Commission, as part of the
39,800,000 doses procured by the Federal Government of Nigeria.
“The NAFDAC team have already taken samples for analysis and
are currently scanning the codes to ensure proper serialisation of the vaccine.
“As of September 6, 2021, a total of 3,600,858 eligible
Nigerians have so far received their first dose of COVID-19 vaccine. This is
made up of 2,551,738 persons vaccinated with AstraZeneca vaccine and 1,049,120
persons vaccinated with Moderna vaccine.
“Therefore, 1,576,011 persons have been fully vaccinated
with AstraZeneca vaccine. We have now restarted the administration of
AstraZeneca as first dose in all designated health facilities.
0 comments:
Post a Comment